FeesSafety
Pluang+

Pulmonx to present at Piper Sandler Healthcare Conference with investor meetings on Dec 2, 2026

Market News
18 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Pulmonx to present at Piper Sandler Healthcare Conference with investor meetings on Dec 2, 2026

Pulmonx Corporation, a leader in minimally invasive lung disease treatments, announced it will participate in a fireside discussion at the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026. The company will also hold in-person investor meetings during the event. Pulmonx is known for its Zephyr® Endobronchial Valve and other technologies for treating severe COPD and emphysema. A live webcast of the discussion will be available on Pulmonx's investor website.

Pulmonx Corporation is set to participate in the Piper Sandler 38th Annual Healthcare Conference. For readers following the health sector, here is Pluang's market snapshot as of Nov 19, 2026 04:02 WIB: Of 150 priced health-sector US stocks tradable on Pluang, 49 rose and 100 fell today. Notable movers include Oscar Health Inc (OSCR) at USD 27.65 with a 1-day change of -7.34% and a typical hold time of 16 days, Aveanna Healthcare Holdings Inc. (AVAH) at USD 10.86 with a 1-day change of -6.82% and 100% sell order activity, and ImmunityBio Inc. (IBRX) at USD 6.68 with a 1-day change of +6.71% and a typical hold time of 5 days.

More News

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical is set to report earnings on November 19, 2026, with expected losses of $0.15 per share and revenue of $125,000. The company announced positive clinical trial results from its U.S. REGAIN trial for Alpha DaRT therapy in glioblastoma...

Company Fundamentals
Bullish
54 minutes ago
Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia's stock dropped 2.9% to $150.96 after initially rising on strong quarterly results and a raised revenue forecast for fiscal 2028, projecting 75% annual growth. However, investor concerns about leadership uncertainty, including calls for former...

Neutral
1 hour ago
B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods increased its full-year net sales and adjusted EBITDA guidance following a 5% volume-driven sales growth in Q3 2026. The company is expanding beyond traditional retail into food service, clubs, and private labels to utilize factory capacity...

Company Fundamentals
Bullish
1 hour ago
CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave's stock fell 4.13% despite strong AI demand and Nvidia's solid earnings, as investors focus on the company's heavy debt and financing challenges. The company reported 168% revenue growth and raised its 2026 revenue forecast to $13-$13.3 bil...

Bearish
1 hour ago
Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group reported a 5.5% net sales increase in fiscal Q1 2027, driven by growth in independent restaurant orders and expanding gross profit margins. The company aims to achieve $125 million in annual procurement savings by fiscal 2028 t...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App